Cicatrix Completed Phase 1 Trials for Avotermin (DB11955)

IndicationStatusPhase
DBCOND0036402 (Cicatrix)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00978302Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)Prevention